PRECIGEN, INC. Amortization of Debt Issuance Costs and Discounts
PRECIGEN, INC. (PGEN) reported Amortization of Debt Issuance Costs and Discounts of $706.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-04
- PRECIGEN, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $361.00K.
- PRECIGEN, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $345.00K.
- PRECIGEN, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $284.00K.
- PRECIGEN, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $72.00K.
- PRECIGEN, INC. amortization of debt issuance costs and discounts for fiscal 2025 was $356.00K.
- PRECIGEN, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PRECIGEN, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $60.00K, a 94.24% decline from fiscal 2022.
- PRECIGEN, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $1.04M, a 91.12% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $361.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $706.00K 10-Q · filed 2026-08-04 | $990.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.06M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $345.00K 10-Q · filed 2026-05-13 | $629.00K derived: sum of 2 quarters · filed 2026-05-13 | $701.00K derived: sum of 3 quarters · filed 2026-05-13 | $701.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $356.00K derived: sum of 2 quarters · filed 2026-03-25 | $356.00K derived: sum of 3 quarters · filed 2026-08-04 | $356.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $72.00K derived: sum of 2 quarters · filed 2026-08-04 | $72.00K 10-Q · filed 2025-11-13 | $72.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $0.00 derived: sum of 3 quarters · filed 2026-05-13 | $0.00 derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $0.00 derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $0.00 derived: sum of 3 quarters · filed 2026-03-25 | $26.00K derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 derived: sum of 2 quarters · filed 2026-03-25 | $26.00K derived: sum of 3 quarters · filed 2026-03-25 | $60.00K 10-K · filed 2026-03-25 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $26.00K derived: sum of 2 quarters · filed 2024-11-14 | $60.00K 10-Q · filed 2024-11-14 | $168.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $60.00K 10-Q · filed 2024-08-14 | $168.00K derived: sum of 3 quarters · filed 2025-03-19 | $506.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2023-03-31 | $34.00K 10-Q · filed 2024-05-14 | $142.00K derived: sum of 2 quarters · filed 2025-03-19 | $480.00K derived: sum of 3 quarters · filed 2025-03-19 | $792.00K derived: sum of 4 quarters · filed 2025-03-19 |
| 2022-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $446.00K derived: sum of 2 quarters · filed 2025-03-19 | $758.00K derived: sum of 3 quarters · filed 2025-03-19 | $1.04M 10-K · filed 2025-03-19 |
| 2022-09-30 | $338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $650.00K derived: sum of 2 quarters · filed 2023-11-09 | $934.00K 10-Q · filed 2023-11-09 | $4.03M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-06-30 | $312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $596.00K 10-Q · filed 2023-08-09 | $3.69M derived: sum of 3 quarters · filed 2024-03-19 | $6.70M derived: sum of 4 quarters · filed 2024-03-19 |
| 2022-03-31 | $284.00K 10-Q · filed 2023-05-10 | $3.38M derived: sum of 2 quarters · filed 2024-03-19 | $6.39M derived: sum of 3 quarters · filed 2024-03-19 | $9.27M derived: sum of 4 quarters · filed 2024-03-19 |
| 2021-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $6.11M derived: sum of 2 quarters · filed 2024-03-19 | $8.98M derived: sum of 3 quarters · filed 2024-03-19 | $11.73M 10-K · filed 2024-03-19 |
| 2021-09-30 | $3.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.89M derived: sum of 2 quarters · filed 2022-11-09 | $8.64M 10-Q · filed 2022-11-09 | $11.42M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $5.63M 10-Q · filed 2022-08-08 | $8.41M derived: sum of 3 quarters · filed 2023-03-06 | $11.12M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $2.75M 10-Q · filed 2022-05-09 | $5.53M derived: sum of 2 quarters · filed 2023-03-06 | $8.24M derived: sum of 3 quarters · filed 2023-03-06 | $10.82M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $5.49M derived: sum of 2 quarters · filed 2023-03-06 | $8.07M derived: sum of 3 quarters · filed 2023-03-06 | $10.59M 10-K · filed 2023-03-06 |
| 2020-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $5.29M derived: sum of 2 quarters · filed 2021-11-08 | $7.81M 10-Q · filed 2021-11-08 | $10.30M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $5.10M 10-Q · filed 2021-08-09 | $7.60M derived: sum of 3 quarters · filed 2022-03-01 | $10.03M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.52M 10-Q · filed 2021-05-10 | $5.01M derived: sum of 2 quarters · filed 2022-03-01 | $7.44M derived: sum of 3 quarters · filed 2022-03-01 | $9.76M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.93M derived: sum of 2 quarters · filed 2022-03-01 | $7.25M derived: sum of 3 quarters · filed 2022-03-01 | $9.46M 10-K · filed 2022-03-01 |
| 2019-09-30 | $2.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $4.75M derived: sum of 2 quarters · filed 2020-11-09 | $6.96M 10-Q · filed 2020-11-09 | $9.22M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $4.53M 10-Q · filed 2020-08-10 | $6.79M derived: sum of 3 quarters · filed 2021-03-01 | $8.91M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $2.21M 10-Q · filed 2020-05-11 | $4.47M derived: sum of 2 quarters · filed 2021-03-01 | $6.59M derived: sum of 3 quarters · filed 2021-03-01 | $6.59M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $4.38M derived: sum of 2 quarters · filed 2021-03-01 | $4.38M derived: sum of 3 quarters · filed 2021-03-01 | $4.38M 10-K · filed 2021-03-01 |
| 2018-09-30 | $2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.12M derived: sum of 2 quarters · filed 2019-11-12 | $2.12M 10-Q · filed 2019-11-12 | $2.12M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |